Global Blood Therapeutics (GBT) (NASDAQ: GBT), based in South SF, is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. We aim to make a significant impact by treating the root cause or making a meaningful difference in the standards of care. Through in-licensing and continued research and development, were committed to Hope+Science+Community.
You can view our social community guidelines at http://www.gbt.com/about/social-community-guidelines/
Global Blood Therapeutics Address
181 Oyster Point Boulevard South San Francisco, CA United States